Tranquil Clinical And Research Consulting Services LLC

Webster, TX

UEI
FWWJT8QCEDY4
CAGE
9Z4C3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Limited Liability Company
  • Black American Owned
Entity structure
Sole Proprietorship
SAM.gov registration date
Physical address
16969 N Texas Ave, Webster, TX 77598, USA
Founded
2013
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Research & Consulting Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $4,114,632

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $4,114,632

Contract awards

Similar vendors

About the company

Tranquil Clinical And Research Consulting Services LLC, a Black American-owned, self-certified small disadvantaged business operating as an LLC sole proprietorship based in Webster, Texas, provides clinical trial execution, bioanalytical testing, and laboratory support services to the Food and Drug Administration as a prime contractor under Total Small Business set-asides. All four of the vendor's recent federal awards fund FDA programs, exclusively, with 100% of combined potential value ($55 million) flowing from the Department of Health and Human Services.

The vendor's footprint centers on a $50 million single-award Indefinite Delivery Indefinite Quantity contract awarded by the FDA on September 15, 2025, to provide clinical trial and laboratory support to the Office of Clinical Pharmacology within the Center for Drug Evaluation and Research. The IDIQ, which runs through September 2030 and carries NAICS 541714 (Research and Development in Biotechnology), is sized for 1,000 employees and explicitly requires capability to conduct multiple clinical trials simultaneously while maintaining full compliance with FDA regulations and International Council for Harmonisation Good Clinical Practice guidelines. Three task orders have issued against the IDIQ to date, carrying a combined potential value of $5 million. The most recent task orders, all issued September 30, 2026, include a $2.1 million delivery order for a proton pump inhibitor pharmacokinetic study running through September 2029 with performance in Silver Spring, Maryland; a $1.6 million DDI clinical pharmacology study completing September 2027 based in Webster, Texas; and a $1.3 million sunscreen absorption clinical pharmacology study also completing September 2027 in Webster. Two awards face ultimate completion within the next twenty-four months with combined potential value of $2.9 million, creating recompete exposure. The vendor has obligated $4.1 million to date against the $55 million combined potential value, representing 7% of ceiling utilization across all awards.

SBA capabilities narrative

Tranquil Clinical Research is an early phase full service CRO and Clinical Research Unit. Tranquil Clinical Research is in the business of providing high quality early phase CRO/CRU services to the biotech and pharma industry. Our unit is a 36 bed free-standing unit in the Clear Lake Medical Center.

Quick answers

Is Tranquil Clinical And Research Consulting Services LLC registered in SAM.gov?

Yes. Tranquil Clinical And Research Consulting Services LLC's SAM.gov registration is active through February 12, 2027.

What is Tranquil Clinical And Research Consulting Services LLC's CAGE code?

Tranquil Clinical And Research Consulting Services LLC's CAGE code is 9Z4C3, and its Unique Entity ID (UEI) is FWWJT8QCEDY4.

How much has Tranquil Clinical And Research Consulting Services LLC received in federal contracts?

Federal contracts obligated $4,114,632 to Tranquil Clinical And Research Consulting Services LLC in fiscal years 2023 through 2027.

What is Tranquil Clinical And Research Consulting Services LLC's most recent federal award?

Tranquil Clinical And Research Consulting Services LLC's most recent federal contract award is FFP task order for proton pump inhibitor PK study for the FDA's center for drug evaluation and research (CDER)… (75F40126F19001), from Food and Drug Administration, on September 30, 2026.

On GovTribe

See Tranquil Clinical And Research Consulting Services LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe